Credit Unions Amass Largest Share of the Automotive Finance Market in Five Years
New Experian report shows ongoing impact of inventory shortage on automotive finance market, as average…
New Experian report shows ongoing impact of inventory shortage on automotive finance market, as average…
SAN JOSE, Calif.–(BUSINESS WIRE)–Scope AR today announced the launch of WorkLink IoT, a platform service…
SAN FRANCISCO–(BUSINESS WIRE)–#agexpansion–Andersen Global continues to solidify its international presence as Andersen in Georgia (formerly…
Proprietary analysis of more than 2 billion public messages from 13,000 organizations will help marketers…
Leveraging Innovation to Drive Sustainability BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–TriMas (NASDAQ: TRS) today announced that its…
U.S. cybersecurity services firm expands security and identity management services with woman-owned business Scottsdale, Ariz.,…
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,”…
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Earlier this year, a national pharmacy benefit manager (PBM) moved a large percentage of its…
Jamie Donadio Jamie Donadio, CFO, Renibus Therapeutics Dr. Bhupinder Singh Dr. Bhupinder Singh, CMO, Renibus…
Transaction expected to significantly advance commercial readiness of NanoSynex’s innovative diagnostics technology platform focused on…
DALLAS, June 02, 2022 (GLOBE NEWSWIRE) — Gradalis, a late-stage stage biotechnology company developing immunotherapies…
Hillstream BioPharma CEO Issues June 2022 Corporate Update Hillstream BioPharma CEO Issues June 2022 Corporate…
NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) — (NASDAQ: SLS) (“SELLAS” or the “Company”), a…
Results support safety and immunogenicity of the vaccine candidate in the highly vulnerable elderly population…
No dedicated treatment currently available for cocaine addiction TEL AVIV, Israel, June 02, 2022 (GLOBE…
New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual…
– Interim proof-of-concept data anticipated from STARGAZE in H1 2023 – First-in-class regenerative, non-immunosuppressive approach…
Net Revenues Increased by 11% to U$ 86 million, with Adjusted EBITDA Up 15% Year-Over-Year…
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage…